Clinical Trial

Swiss Primary Sclerosing Cholangitis Cohort Study

Name: Swiss Primary Sclerosing Cholangitis Cohort Study — clinical trial record (NCT03146936)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2017-05-08; most recent amendment 2025-08-14.

Trial Details

NCT Number	NCT03146936
Lead Sponsor	Fondazione Epatocentro Ticino
Conditions	Cholangitis, Sclerosing, PSC, Primary Sclerosing Cholangitis (PSC)
Enrollment	120 participants
Start Date	2017-02-28
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-19